Robert H. Shoemaker - Concepedia

Author

Robert H. Shoemaker

Also Known As

R H Shoemaker, R SHOEMAKER, R Shoemaker, R. H. SHOEMAKER, R. H. Shoemaker, R. Shoemaker, R.H. Shoemaker, ROBERT SHOEMAKER, Robert H Shoemaker, Robert H. Shoemaker

340

Publications

24.2K

Citations

H-Index

131

Concepts

All Affiliations

National Cancer Institute Frederick National Laboratory for Cancer Research Science Applications International Corporation (United States)National Institutes of Health Center for Cancer Research

About

Robert H. Shoemaker is an author at National Cancer Institute specializing in medicine, pharmacology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	66	10.9K
2	Natural Sciences	15	16	3.7K
3	Engineering	6	6	319
4	Health Sciences	3	3	102
5	Social Sciences	1	1	12

Robert H. Shoemaker

134

Publications

20.9K

Citations

H-Index

Page 1

	Year	Citations
Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines Anne Monks, Dominic A. Scudiero, Philip Skehan, JNCI Journal of the National Cancer Institute	1991	3.2K
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Michael C. Alley, Dominic A. Scudiero, Anne Monks, PubMed Chemoprevention StrategyTumor BiologyMicroculture Tetrazolium AssayOncologyCancer Detection	1988	3.1K
Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Dominic A. Scudiero, Robert H. Shoemaker, Kenneth D. Paull, PubMed Chemoprevention StrategyPathologyCell CultureMetronomic ChemotherapyCell Growth	1988	2.4K
Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm Kenneth D. Paull, Robert H. Shoemaker, Louis Hodes, JNCI Journal of the National Cancer Institute	1989	960
Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines Larry Rubinstein, Robert H. Shoemaker, Kenneth D. Paull, JNCI Journal of the National Cancer Institute	1990	927
New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity O. S. Weislow, Rebecca Kiser, Donald L. Fine, JNCI Journal of the National Cancer Institute Molecular PharmacologyHigh-flux ScreeningNew Soluble-formazan AssayRebecca Kiser SearchMedicine	1989	689
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development Michael R. Boyd, Kirk R. Gustafson, James B. McMahon, Antimicrobial Agents and Chemotherapy Viral ReplicationImmunologyEscherichia ColiAntiviral DrugSimian Immunodeficiency Virus	1997	607
Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding Activity Dehe Kong, Eun‐Jung Park, Andrew G. Stephen, Cancer Research	2005	506
Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Annamaria Rapisarda, Badarch Uranchimeg, Dominic A. Scudiero, PubMed Small Molecule InhibitorsCancer BiologyGliomaTumor BiologyOxidative Stress	2002	458
Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis <i>In vitro</i> and <i>In vivo</i> Joell J. Gills, Jaclyn LoPiccolo, Junji Tsurutani, Clinical Cancer Research	2007	326

Page 1